CHEMOMAB THERAPEUTICS LTD shareholder history

Current and past CHEMOMAB THERAPEUTICS LTD shareholders
Period Weighting Quarter
CompanyLongestShortestMin.Avg.Max.FirstLatest↓ Count
BOOTHBAY FUND MANAGEMENT, LLC 11110.00%0.01%0.07%Q1 2021Q3 202311
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 11110.00%0.00%0.00%Q1 2021Q3 202311
Orbimed Advisors 11110.04%0.23%0.69%Q1 2021Q3 202311
Ikarian Capital, LLC 10100.02%0.18%0.45%Q2 2021Q3 202310
UBS Group AG 550.00%0.00%0.00%Q1 2021Q3 202310
MORGAN STANLEY 540.00%0.00%0.00%Q1 2021Q2 20239
OSAIC HOLDINGS, INC. 990.00%0.00%0.00%Q3 2021Q3 20239
GEODE CAPITAL MANAGEMENT, LLC 990.00%0.00%0.00%Q3 2021Q3 20239
Newbridge Financial Services Group, Inc. 770.00%0.00%0.00%Q1 2022Q3 20237
MEITAV INVESTMENT HOUSE LTD 660.00%0.01%0.02%Q1 2021Q2 20226
ROYAL BANK OF CANADA 660.00%0.00%0.00%Q1 2022Q2 20236
Cormorant Asset Management, LP 550.03%0.07%0.11%Q1 2022Q1 20235
STATE STREET CORP 550.00%0.00%0.00%Q3 2021Q3 20225
KESTRA PRIVATE WEALTH SERVICES, LLC 440.00%0.00%0.01%Q4 2022Q3 20234
ENVESTNET ASSET MANAGEMENT INC 440.00%0.00%0.00%Q1 2022Q4 20224
ARK Investment Management 330.00%0.00%0.01%Q3 2021Q1 20223
Ironwood Financial, llc 330.00%0.00%0.00%Q1 2021Q3 20213
CREDIT SUISSE AG/ 220.00%0.00%0.00%Q3 2022Q4 20222
RHUMBLINE ADVISERS 220.00%0.00%0.00%Q2 2023Q3 20232
Spire Wealth Management 220.00%0.00%0.00%Q2 2021Q3 20212
Tower Research Capital LLC (TRC) 110.00%0.00%0.00%Q1 2021Q3 20212
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 220.02%0.02%0.03%Q3 2021Q4 20212
Virtu Financial LLC 110.02%0.02%0.02%Q2 2021Q4 20212
JPMORGAN CHASE & CO 110.00%0.00%0.00%Q2 2021Q1 20222
Renaissance Technologies 110.00%0.00%0.00%Q1 2021Q1 20222
Apollon Wealth Management, LLC 220.01%0.01%0.02%Q3 2021Q4 20212
Activest Wealth Management 220.01%0.01%0.01%Q3 2022Q4 20222
CVI Holdings, LLC 110.19%0.19%0.19%Q1 2021Q1 20211
Moser Wealth Advisors, LLC 110.00%0.00%0.00%Q3 2023Q3 20231
Qube Research & Technologies Ltd 110.00%0.00%0.00%Q3 2023Q3 20231
Marshall Wace North America L.P. 110.00%0.00%0.00%Q2 2021Q2 20211
MARSHALL WACE, LLP 110.01%0.01%0.01%Q2 2021Q2 20211
Citadel Advisors 110.00%0.00%0.00%Q3 2022Q3 20221
Maven Securities LTD 110.16%0.16%0.16%Q1 2021Q1 20211
TWO SIGMA ADVISERS, LP 110.00%0.00%0.00%Q1 2023Q1 20231
GSA CAPITAL PARTNERS LLP 110.01%0.01%0.01%Q4 2021Q4 20211
Urban Wealth Management, LLC 110.03%0.03%0.03%Q2 2022Q2 20221
TWO SIGMA INVESTMENTS, LP 110.00%0.00%0.00%Q1 2023Q1 20231
External links

This page lists all the filers that currently own CHEMOMAB THERAPEUTICS LTD or have owned CHEMOMAB THERAPEUTICS LTD in the past.